Our Reports
Automotive ReportsElectronics & SemiconductorTelecom & ITTechnology & ITConsumer GoodsHealthcareFood & BeveragesChemical
Our Links
About UsContact UsPress ReleaseNewsOur Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Global Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Regional Outlook and Forecast, 2022 - 2028

Published Date : 31-May-2022

Pages: 377

Formats: PDF

COVID-19 Impact on the Sepsis Diagnostics Market

The Global Sepsis Diagnostics Market size is expected to reach $879.5 million by 2028, rising at a market growth of 8.3% CAGR during the forecast period.

Sepsis is a medical disorder that emerges as a result of the body's response to infections caused by bacteria, viruses, or fungus. The immune system produces various substances into the bloodstream in this situation, causing hyper inflammation and the production of blood clots. Multiple organ failures, rapid breathing, neurological dysfunction, low blood pressure, and a higher heart rate are all possible complications of sepsis. Molecular diagnosis, biomarkers, flow cytometry, immunoassays, microfluidics, and other processes are used to diagnose sepsis. Hospitals, pathology and reference laboratories, university academic researchers, and other institutions are all using these diagnostic tools.

In 2016, the Third International Sepsis Consensus Task Force determined the current criteria for clinical sepsis diagnosis, known as Sequential Organ Failure Assessment (SOFA). This scoring system detects cumulative organ dysfunction as a result of an infection-induced dysregulation of the host's immune system. Cardiovascular function, respiration, liver function, coagulation, central nervous system function, and renal function are all regarded in the SOFA score.

A point is given for each malfunctioning organ system, with a score of 2 points or higher indicating a definite sepsis diagnosis. A high SOFA score is linked to a higher than 10% hospital mortality risk. Quick SOFA (qSOFA) is a rapid alternative to SOFA that uses only a subset of the SOFA scoring criteria, such as abnormal mentation, systolic blood pressure under 100 mm Hg, and a breathing rate of 22 or more per minute. qSOFA does not necessitate laboratory testing and can be performed as many times as needed.

SOFA replaces the Systemic Inflammatory Response Syndrome (SIRS) criteria, which was created in 2001. SIRS scoring requires two or more of the following: a temperature of greater than 38°C or less than 36°C, a heart rate of greater than 90 beats per minute, a respiratory rate of greater than 20 beats per minute, or a white blood cell count of greater than 12,000/L or less than 4,000/L. When compared to SIRS and qSOFA, SOFA has higher predictive accuracy.

Sepsis Diagnostics Market Size - Global Opportunities and Trends Analysis Report 2018-2028

COVID-19 Impact Analysis

The COVID-19 pandemic had a marginally beneficial impact on sepsis diagnostics sales. The widespread of COVID-19 and the emergence of sepsis cases among COVID-19 patients are projected to boost the demand for quick diagnosis, speeding up the use of tools, reagents, and test kits for sepsis detection. COVID-19 infection is more likely to affect surgeons and patients undergoing a variety of procedures in hospitals. The bulk of sepsis diagnostics was halted, leading to a decrease in device-based treatments. People postponed health exams as a result of the pandemic's lockdowns, lowering the number of tests conducted and laboratory sales.

Market Growth Factors

A rise in the number of hospital-acquired illnesses

HAIs also characterized as nosocomial infections, a prominent cause of morbidity and mortality in hospitals across the world. The most common hospital-acquired illnesses include urinary tract infections, pneumonia, and sepsis (HAIs). HAIs can induce sepsis in immunocompromised people, the elderly, and people with medical conditions. According to the Centres for Disease Control and Prevention (CDC), sepsis affects at least 1.7 million adults in the United States each year, with about 270,000 deaths. An illness obtained at a medical facility, such as an inpatient setting or a skilled nursing care facility, is characterized as a healthcare-acquired infection (HAI). An HAI might come from anywhere, even a doctor's office or clinic. HAIs are known as nosocomial infections in the medical world. Infections acquired outside of a healthcare centre are known as community-acquired infections.

The rapidly growing Molecular Diagnostics market

Due to their ease of use and effectiveness in diagnostic procedures, molecular diagnostics has attracted a number of multinational companies and institutes. The gold standard for molecular diagnostic methods has been blood culture analysis for quick and precise infection profiling. Several firms are investing in point-of-care molecular diagnostics to improve patient management and early detection of bacterial and viral infections. For example, Immunexpress debuted a quick SeptiCyte, a one-hour molecular diagnostic test for sepsis, on Biocartis' Idylla platform in October 2020. This is one of the first completely integrated, immune response-based diagnostics to help clinicians diagnose sepsis.

Market Restraining Factors

High expense of automated diagnostic instruments

Companies are focusing on creating automated diagnostic instruments for identifying sepsis based on modern technologies such as molecular diagnostics. However, government hospitals and scientific research laboratories cannot acquire such systems due to budget constraints. Furthermore, it is becoming a key impediment to the expansion of the sepsis diagnostics market. In addition, the lowest intensity sepsis cohort population had the major burden of recurrence and total expenses. Sepsis cases that were not discovered until hospitalization, along with those with increasing severity, had a greater economic cost and death rate on a case-by-case basis.

Sepsis Diagnostics MarketMarket Share and Industry Analysis Report 2021

Method Outlook

Based on Method, the market is segmented into Conventional and Automated. The automated segment witnessed a substantial revenue share in the Sepsis Diagnostics Market in 2021. The use of billing codes and the installation of predictable evaluation are based on agreement definitions that have been used in efforts to automate sepsis identification. Although billing codes are simple to extract and have a strong positive predictive value (PPV) for sepsis, they typically do not document the onset of sepsis and have low sensitivity when compared to clinician assessment. Changing medical practicing habits and reimbursement policies also have an impact on them. Consensus-based definitions have improved over time and across institutions, but they still rely on doctors to validate if organ dysfunction is attributable to sepsis, resulting in low PPV when automated.

Test Type Outlook

Based on Test Type, the market is segmented into Laboratory Tests and Point-of-Care Tests. The laboratory tests procured the highest revenue share in the Sepsis Diagnostics Market in 2021. This is mostly attributable to the fact that laboratory testing is more accurate than POC testing when it comes to identifying sepsis. Laboratory testing allows for a comprehensive examination of the pathogen and its medication resistance profile. In addition, routine lactate testing, which is a vague but valuable indication of sepsis, is done efficiently in laboratory settings. The public's and physicians' dependence on these labs has grown dramatically with the introduction of technologically advanced products.

Pathogen Outlook

Based on Pathogen, the market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others. The fungal sepsis recorded a substantial revenue share in the Sepsis Diagnostics Market in 2021. Fungi are responsible for about 15% of all infections, and invasive fungal infections are becoming a more common cause of sepsis, especially in critically ill patients. This disease are life-threatening illness that can occur anywhere in the body as a result of an infection. Severe instances of sepsis are frequently caused by infections that spread throughout the body and through the bloodstream.

Product Outlook

Based on Product, the market is segmented into Blood Culture Media, Assays & Reagents, Instruments, and Software. The software segment registered a substantial revenue share in the Sepsis Diagnostics Market in 2021. This rapid expansion of this segment can be ascribed to a rise in healthcare professionals' implementation of modern software platforms for better sepsis detection and management. For example, Guthrie, anintegrated health care system, used Wolters Kluwer's POC Advisor to diagnose and treat sepsis at four local hospitals in September 2019.

End-User Outlook

Based on End-User, the market is segmented into Hospitals & specialty clinics, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. The hospitals and specialty clinics segment procured the highest revenue share in the Sepsis Diagnostics Market in 2021. The rising number of patients diagnosed with sepsis, and in-house hospital and clinics are undertaking a large number of blood culture tests to identify blood stream infections (BSIs caused by bacteria, fungi/yeast, or viruses) contribute to the increased growth of this segment.

Technology Outlook

Based on Technology, the market is segmented into Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers. The blood culture segment garnered the largest revenue share in the Sepsis Diagnostics Market in 2021. One of the most significant investigations in the treatment of sepsis is blood culture. It enables the identification of the sepsis-causing bacterium, the selection of a relevant empirical and specific antibiotic, and the identification of the infection's focal location. All sepsis patients should have a blood culture taken. Sepsis is traditionally described as the presence of infection-induced systemic inflammatory response syndrome (SIRS). Moreover, the affordable pricing of microbiological techniques and the widespread usage of blood culture procedures for sepsis diagnosis also account for this proportion.

Anastomosis Devices Market Report Coverage
Report Attribute Details
Market size value in 2021 USD 511.3 Million
Market size forecast in 2028 USD 879.5 Million
Base Year 2021
Historical Period 2018 to 2020
Forecast Period 2022 to 2028
Revenue Growth Rate CAGR of 8.3% from 2022 to 2028
Number of Pages 378
Number of Tables 655
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered Method, Test Type, Pathogen, Product, End-User, Technology, Region
Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers
  • A rise in the number of hospital-acquired illnesses
  • The rapidly growing Molecular Diagnostics market
Restraints
  • High expense of automated diagnostic instruments

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The North America segment acquired the highest revenue share in the Sepsis Diagnostics Market in 2021. The medical device market in North America is well-established. The presence of a well-developed healthcare system, widespread implementation of innovative sepsis diagnosing technologies between health personnel, a reducing number of surgical procedures, growing prevalence of healthcare-associated infections (HAIs), and adoption of advanced technologies of sepsis diagnostics are all key factors that drive the sepsis diagnostics market in North America.

Free Valuable Insights: Global Sepsis Diagnostics MarketMarket size to reach USD 879.5 Million by 2028

KBV Cardinal Matrix - Sepsis Diagnostics MarketMarket Competition Analysis

Sepsis Diagnostics MarketMarket - Competitive Landscape and Trends by Forecast 2028

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. is the major forerunner in the Sepsis Diagnostics Market. Companies such as Thermo Fisher Scientific, Inc., Bruker Corporation and BioMérieux S.A. are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Recent Strategies Deployed in Sepsis Diagnostics Market

» Partnerships, Collaborations and Agreements

  • Jan-2022: Oncocyte Corporation signed a development and co-marketing agreement with Thermo Fisher Scientific, an American supplier of scientific instrumentation, reagents and consumables, and software services. This agreement aimed to distribute Vitro diagnostic evaluation on Thermo Fisher Scientific’s Ion Torrent Genexus System. Additionally, Oncocyte would clinically approve Thermo Fisher’s existing Oncomine complete Assay Plus on the Genexus System, paving the way toward IVD authorization for use in tumour mark and future resignation as a companion diagnostic.
  • Sep-2021: Thermo Fisher Scientific joined hands with AstraZeneca, a multinational pharmaceutical and biotechnology company. Together, the companies aimed to co-build NGS-based companion diagnostics to support AstraZeneca’s expanding offering of address therapies. Additionally, Thermo Fisher would provide the expertise, technology, and capabilities to disperse CDx tests to local healthcare suppliers around our global markets, which would help in identifying more patients across the world who may asset from effective patient care and treatments.
  • Sep-2021: Siemens Healthineers joined hands with A1 Life Sciences, a pioneering biotechnology company. Together, the companies aimed to support global attempts to record variants of SARS-CoV-2, allowing Siemens Healthineers to provide a developing offering of PCR-based appraisal for the recognization of SARS-CoV-2 variants and mutations.
  • Apr-2021: DiaSorin came into a definitive merger agreement for DiaSorin to acquire Luminex Corporation. Under this acquisition DiaSorin would gain approach to Luminex's molecular diagnostics multiplexing technology and a offering that would reinforce its existing suite while expanding its presence in the U.S.
  • Mar-2021: Roche signed an agreement to acquire GenMark Diagnostics, a leading provider of multiplex molecular diagnostic solutions. Under the terms of the merger agreement, Roche would directly commence a tender provide to obtain all outstanding shares of GenMark’s common stock. Additionally, GenMark would file a endorsement statement containing the united recommendation of the GenMark board that GenMark stockholders delicate shares to Roche.

» Product Launches and Product Expansions

  • Dec-2021: BD expanded the BD COR System by including a new MX instrument. This expansion aimed to assist proteomic molecular testing for contagious diseases. Additionally, the MX instrument is designed to prove BD MAX System molecular PCR technology platform, a medium-throughput system usually found in hospital labs, and BD aims to use the BD MAX System menu of contagious disease trail to generate assays that can be achieved in high-throughput central reference labs on the BD COR System
  • Jul-2020: Bruker Corporation introduced FluoroType SARS-CoV-2 along with next-generation 6-plex PCR. The medicine appraisal for the highly specific observation of the SARS-CoV-2 virus, which causes systemic and respiratory disease. Additionally, FluoroType SARS-CoV-2 plus estimation is CE-IVD characterised as per the European IVD Directive. Moreover, two clinical testings require almost ninety CV19 positive patients and over 100 CV19 negative individuals, this enhanced CV19 infection estimation showed 100% specificity and sensitivity.

» Acquisitions and Mergers

  • Dec-2021: Thermo Fisher Scientific completed the acquisition of PPD, a global contract research organization. Under this acquisition, Thermo Fisher planned to deliver an entire offering of services around the clinical development spectrum, handling trial logistics, efficacy and healthcare outcome assessment, safety, comprising scientific discovery, along with the production and advancement of the therapeutics.
  • Dec-2021: Quidel Corporation completed the acquisition of Ortho Clinical Diagnostics Holdings, an in vitro diagnostics company. Under this acquisition, Ortho would assist concrete Quidel as a leader in the diagnostics companies, bringing together complementary products, innovative, services, and solutions that improve the health and well-being of patients around the world.
  • Sep-2021: Abbott took over Walk Vascular, a commercial-stage medical device enterprise. Through this acquisition, Walk Vascular would integrate within the vascular device portfolio and further propel Abbott's capabilities to deliver one-of-a-kind endovascular treatment solutions to enhance patient care.
  • Apr-2021: Siemens Healthineers took over Varian Medical Systems, an American radiation oncology treatments and software developer. With this acquisition, Siemens Healthineers has the most complete suite in the MedTech sector, which provides the enterprise with appreciable potential for value creation. Additionally, Siemens Healthineer's integrated approach would take the broad fight against cancer to a new level.
  • Jan-2021: Thermo Fisher Scientific completed the acquisition of Mesa Biotech, a molecular diagnostic company. Under this acquisition, Mesa Biotech's convenient quick PCR-based test would highly integral to the existing portfolio and would further assist to fulfil the constant demand for COVID-related checking while the company works to rapidly scale and advance point-of-care tests for other contagious diseases in the future.

» Approvals and Trials

  • Mar-2021: Thermo Fisher Scientific received FDA approval for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The PCR System would clarify abilities to workflow decrease steps to provide quality results in less than 30 minutes. Moreover, the PCR system has high sensitivity and precision as well as delivers up to six channels for multiplexing.
  • Sep-2020: Roche received FDA approval for Elecsys HIV Duo immunoassay. The approval enables a strong complete infectious diseases menu on the Cobas e 801 system and is a compelling step towards bringing integrative value to the U.S. market within the area of contagious diseases.

Scope of the Study

Market Segments Covered in the Report:

By Method

  • Conventional
  • Automated

By Test Type

  • Laboratory Tests
  • Point-of-Care Tests

By Pathogen

  • Bacterial Sepsis
  • Fungal Sepsis
  • Viral Sepsis
  • Others

By Product

  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software

By End-User

  • Hospitals & specialty clinics
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

By Technology

  • Blood Culture
  • Immunoassays
  • Molecular Diagnostics
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • BioMérieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • DiaSorin S.p.A.
  • Bruker Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Quidel Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Sepsis Diagnostics Market, by Method
1.4.2 Global Sepsis Diagnostics Market, by Test Type
1.4.3 Global Sepsis Diagnostics Market, by Pathogen
1.4.4 Global Sepsis Diagnostics Market, by Product
1.4.5 Global Sepsis Diagnostics Market, by End-User
1.4.6 Global Sepsis Diagnostics Market, by Technology
1.4.7 Global Sepsis Diagnostics Market, by Geography
1.5 Methodology for the research


Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints


Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2021, Dec) Leading Players


Chapter 4. Global Sepsis Diagnostics Market by Method
4.1 Global Conventional Market by Region
4.2 Global Automated Market by Region


Chapter 5. Global Sepsis Diagnostics Market by Test Type
5.1 Global Laboratory Tests Market by Region
5.2 Global Point-of-Care Tests Market by Region


Chapter 6. Global Sepsis Diagnostics Market by Pathogen
6.1 Global Bacterial Sepsis Market by Region
6.2 Global Fungal Sepsis Market by Region
6.3 Global Viral Sepsis Market by Region
6.4 Global Others Market by Region


Chapter 7. Global Sepsis Diagnostics Market by Product
7.1 Global Blood Culture Media Market by Region
7.2 Global Assays & Reagents Market by Region
7.3 Global Instruments Market by Region
7.4 Global Software Market by Region


Chapter 8. Global Sepsis Diagnostics Market by End-User
8.1 Global Hospitals & specialty clinics Market by Region
8.2 Global Pathology & Reference Laboratories Market by Region
8.3 Global Research Laboratories & Academic Institutes Market by Region


Chapter 9. Global Sepsis Diagnostics Market by Technology
9.1 Global Blood Culture Market by Region
9.2 Global Immunoassays Market by Region
9.3 Global Molecular Diagnostics Market by Region
9.4 Global Flow Cytometry Market by Region
9.5 Global Microfluidics Market by Region
9.6 Global Biomarkers Market by Region


Chapter 10. Global Sepsis Diagnostics Market by Region
10.1 North America Sepsis Diagnostics Market
10.1.1 North America Sepsis Diagnostics Market by Method
10.1.1.1 North America Conventional Market by Country
10.1.1.2 North America Automated Market by Country
10.1.2 North America Sepsis Diagnostics Market by Test Type
10.1.2.1 North America Laboratory Tests Market by Country
10.1.2.2 North America Point-of-Care Tests Market by Country
10.1.3 North America Sepsis Diagnostics Market by Pathogen
10.1.3.1 North America Bacterial Sepsis Market by Country
10.1.3.2 North America Fungal Sepsis Market by Country
10.1.3.3 North America Viral Sepsis Market by Country
10.1.3.4 North America Others Market by Country
10.1.4 North America Sepsis Diagnostics Market by Product
10.1.4.1 North America Blood Culture Media Market by Country
10.1.4.2 North America Assays & Reagents Market by Country
10.1.4.3 North America Instruments Market by Country
10.1.4.4 North America Software Market by Country
10.1.5 North America Sepsis Diagnostics Market by End-User
10.1.5.1 North America Hospitals & specialty clinics Market by Country
10.1.5.2 North America Pathology & Reference Laboratories Market by Country
10.1.5.3 North America Research Laboratories & Academic Institutes Market by Country
10.1.6 North America Sepsis Diagnostics Market by Technology
10.1.6.1 North America Blood Culture Market by Country
10.1.6.2 North America Immunoassays Market by Country
10.1.6.3 North America Molecular Diagnostics Market by Country
10.1.6.4 North America Flow Cytometry Market by Country
10.1.6.5 North America Microfluidics Market by Country
10.1.6.6 North America Biomarkers Market by Country
10.1.7 North America Sepsis Diagnostics Market by Country
10.1.7.1 US Sepsis Diagnostics Market
10.1.7.1.1 US Sepsis Diagnostics Market by Method
10.1.7.1.2 US Sepsis Diagnostics Market by Test Type
10.1.7.1.3 US Sepsis Diagnostics Market by Pathogen
10.1.7.1.4 US Sepsis Diagnostics Market by Product
10.1.7.1.5 US Sepsis Diagnostics Market by End-User
10.1.7.1.6 US Sepsis Diagnostics Market by Technology
10.1.7.2 Canada Sepsis Diagnostics Market
10.1.7.2.1 Canada Sepsis Diagnostics Market by Method
10.1.7.2.2 Canada Sepsis Diagnostics Market by Test Type
10.1.7.2.3 Canada Sepsis Diagnostics Market by Pathogen
10.1.7.2.4 Canada Sepsis Diagnostics Market by Product
10.1.7.2.5 Canada Sepsis Diagnostics Market by End-User
10.1.7.2.6 Canada Sepsis Diagnostics Market by Technology
10.1.7.3 Mexico Sepsis Diagnostics Market
10.1.7.3.1 Mexico Sepsis Diagnostics Market by Method
10.1.7.3.2 Mexico Sepsis Diagnostics Market by Test Type
10.1.7.3.3 Mexico Sepsis Diagnostics Market by Pathogen
10.1.7.3.4 Mexico Sepsis Diagnostics Market by Product
10.1.7.3.5 Mexico Sepsis Diagnostics Market by End-User
10.1.7.3.6 Mexico Sepsis Diagnostics Market by Technology
10.1.7.4 Rest of North America Sepsis Diagnostics Market
10.1.7.4.1 Rest of North America Sepsis Diagnostics Market by Method
10.1.7.4.2 Rest of North America Sepsis Diagnostics Market by Test Type
10.1.7.4.3 Rest of North America Sepsis Diagnostics Market by Pathogen
10.1.7.4.4 Rest of North America Sepsis Diagnostics Market by Product
10.1.7.4.5 Rest of North America Sepsis Diagnostics Market by End-User
10.1.7.4.6 Rest of North America Sepsis Diagnostics Market by Technology
10.2 Europe Sepsis Diagnostics Market
10.2.1 Europe Sepsis Diagnostics Market by Method
10.2.1.1 Europe Conventional Market by Country
10.2.1.2 Europe Automated Market by Country
10.2.2 Europe Sepsis Diagnostics Market by Test Type
10.2.2.1 Europe Laboratory Tests Market by Country
10.2.2.2 Europe Point-of-Care Tests Market by Country
10.2.3 Europe Sepsis Diagnostics Market by Pathogen
10.2.3.1 Europe Bacterial Sepsis Market by Country
10.2.3.2 Europe Fungal Sepsis Market by Country
10.2.3.3 Europe Viral Sepsis Market by Country
10.2.3.4 Europe Others Market by Country
10.2.4 Europe Sepsis Diagnostics Market by Product
10.2.4.1 Europe Blood Culture Media Market by Country
10.2.4.2 Europe Assays & Reagents Market by Country
10.2.4.3 Europe Instruments Market by Country
10.2.4.4 Europe Software Market by Country
10.2.5 Europe Sepsis Diagnostics Market by End-User
10.2.5.1 Europe Hospitals & specialty clinics Market by Country
10.2.5.2 Europe Pathology & Reference Laboratories Market by Country
10.2.5.3 Europe Research Laboratories & Academic Institutes Market by Country
10.2.6 Europe Sepsis Diagnostics Market by Technology
10.2.6.1 Europe Blood Culture Market by Country
10.2.6.2 Europe Immunoassays Market by Country
10.2.6.3 Europe Molecular Diagnostics Market by Country
10.2.6.4 Europe Flow Cytometry Market by Country
10.2.6.5 Europe Microfluidics Market by Country
10.2.6.6 Europe Biomarkers Market by Country
10.2.7 Europe Sepsis Diagnostics Market by Country
10.2.7.1 Germany Sepsis Diagnostics Market
10.2.7.1.1 Germany Sepsis Diagnostics Market by Method
10.2.7.1.2 Germany Sepsis Diagnostics Market by Test Type
10.2.7.1.3 Germany Sepsis Diagnostics Market by Pathogen
10.2.7.1.4 Germany Sepsis Diagnostics Market by Product
10.2.7.1.5 Germany Sepsis Diagnostics Market by End-User
10.2.7.1.6 Germany Sepsis Diagnostics Market by Technology
10.2.7.2 UK Sepsis Diagnostics Market
10.2.7.2.1 UK Sepsis Diagnostics Market by Method
10.2.7.2.2 UK Sepsis Diagnostics Market by Test Type
10.2.7.2.3 UK Sepsis Diagnostics Market by Pathogen
10.2.7.2.4 UK Sepsis Diagnostics Market by Product
10.2.7.2.5 UK Sepsis Diagnostics Market by End-User
10.2.7.2.6 UK Sepsis Diagnostics Market by Technology
10.2.7.3 France Sepsis Diagnostics Market
10.2.7.3.1 France Sepsis Diagnostics Market by Method
10.2.7.3.2 France Sepsis Diagnostics Market by Test Type
10.2.7.3.3 France Sepsis Diagnostics Market by Pathogen
10.2.7.3.4 France Sepsis Diagnostics Market by Product
10.2.7.3.5 France Sepsis Diagnostics Market by End-User
10.2.7.3.6 France Sepsis Diagnostics Market by Technology
10.2.7.4 Russia Sepsis Diagnostics Market
10.2.7.4.1 Russia Sepsis Diagnostics Market by Method
10.2.7.4.2 Russia Sepsis Diagnostics Market by Test Type
10.2.7.4.3 Russia Sepsis Diagnostics Market by Pathogen
10.2.7.4.4 Russia Sepsis Diagnostics Market by Product
10.2.7.4.5 Russia Sepsis Diagnostics Market by End-User
10.2.7.4.6 Russia Sepsis Diagnostics Market by Technology
10.2.7.5 Spain Sepsis Diagnostics Market
10.2.7.5.1 Spain Sepsis Diagnostics Market by Method
10.2.7.5.2 Spain Sepsis Diagnostics Market by Test Type
10.2.7.5.3 Spain Sepsis Diagnostics Market by Pathogen
10.2.7.5.4 Spain Sepsis Diagnostics Market by Product
10.2.7.5.5 Spain Sepsis Diagnostics Market by End-User
10.2.7.5.6 Spain Sepsis Diagnostics Market by Technology
10.2.7.6 Italy Sepsis Diagnostics Market
10.2.7.6.1 Italy Sepsis Diagnostics Market by Method
10.2.7.6.2 Italy Sepsis Diagnostics Market by Test Type
10.2.7.6.3 Italy Sepsis Diagnostics Market by Pathogen
10.2.7.6.4 Italy Sepsis Diagnostics Market by Product
10.2.7.6.5 Italy Sepsis Diagnostics Market by End-User
10.2.7.6.6 Italy Sepsis Diagnostics Market by Technology
10.2.7.7 Rest of Europe Sepsis Diagnostics Market
10.2.7.7.1 Rest of Europe Sepsis Diagnostics Market by Method
10.2.7.7.2 Rest of Europe Sepsis Diagnostics Market by Test Type
10.2.7.7.3 Rest of Europe Sepsis Diagnostics Market by Pathogen
10.2.7.7.4 Rest of Europe Sepsis Diagnostics Market by Product
10.2.7.7.5 Rest of Europe Sepsis Diagnostics Market by End-User
10.2.7.7.6 Rest of Europe Sepsis Diagnostics Market by Technology
10.3 Asia Pacific Sepsis Diagnostics Market
10.3.1 Asia Pacific Sepsis Diagnostics Market by Method
10.3.1.1 Asia Pacific Conventional Market by Country
10.3.1.2 Asia Pacific Automated Market by Country
10.3.2 Asia Pacific Sepsis Diagnostics Market by Test Type
10.3.2.1 Asia Pacific Laboratory Tests Market by Country
10.3.2.2 Asia Pacific Point-of-Care Tests Market by Country
10.3.3 Asia Pacific Sepsis Diagnostics Market by Pathogen
10.3.3.1 Asia Pacific Bacterial Sepsis Market by Country
10.3.3.2 Asia Pacific Fungal Sepsis Market by Country
10.3.3.3 Asia Pacific Viral Sepsis Market by Country
10.3.3.4 Asia Pacific Others Market by Country
10.3.4 Asia Pacific Sepsis Diagnostics Market by Product
10.3.4.1 Asia Pacific Blood Culture Media Market by Country
10.3.4.2 Asia Pacific Assays & Reagents Market by Country
10.3.4.3 Asia Pacific Instruments Market by Country
10.3.4.4 Asia Pacific Software Market by Country
10.3.5 Asia Pacific Sepsis Diagnostics Market by End-User
10.3.5.1 Asia Pacific Hospitals & specialty clinics Market by Country
10.3.5.2 Asia Pacific Pathology & Reference Laboratories Market by Country
10.3.5.3 Asia Pacific Research Laboratories & Academic Institutes Market by Country
10.3.6 Asia Pacific Sepsis Diagnostics Market by Technology
10.3.6.1 Asia Pacific Blood Culture Market by Country
10.3.6.2 Asia Pacific Immunoassays Market by Country
10.3.6.3 Asia Pacific Molecular Diagnostics Market by Country
10.3.6.4 Asia Pacific Flow Cytometry Market by Country
10.3.6.5 Asia Pacific Microfluidics Market by Country
10.3.6.6 Asia Pacific Biomarkers Market by Country
10.3.7 Asia Pacific Sepsis Diagnostics Market by Country
10.3.7.1 China Sepsis Diagnostics Market
10.3.7.1.1 China Sepsis Diagnostics Market by Method
10.3.7.1.2 China Sepsis Diagnostics Market by Test Type
10.3.7.1.3 China Sepsis Diagnostics Market by Pathogen
10.3.7.1.4 China Sepsis Diagnostics Market by Product
10.3.7.1.5 China Sepsis Diagnostics Market by End-User
10.3.7.1.6 China Sepsis Diagnostics Market by Technology
10.3.7.2 Japan Sepsis Diagnostics Market
10.3.7.2.1 Japan Sepsis Diagnostics Market by Method
10.3.7.2.2 Japan Sepsis Diagnostics Market by Test Type
10.3.7.2.3 Japan Sepsis Diagnostics Market by Pathogen
10.3.7.2.4 Japan Sepsis Diagnostics Market by Product
10.3.7.2.5 Japan Sepsis Diagnostics Market by End-User
10.3.7.2.6 Japan Sepsis Diagnostics Market by Technology
10.3.7.3 India Sepsis Diagnostics Market
10.3.7.3.1 India Sepsis Diagnostics Market by Method
10.3.7.3.2 India Sepsis Diagnostics Market by Test Type
10.3.7.3.3 India Sepsis Diagnostics Market by Pathogen
10.3.7.3.4 India Sepsis Diagnostics Market by Product
10.3.7.3.5 India Sepsis Diagnostics Market by End-User
10.3.7.3.6 India Sepsis Diagnostics Market by Technology
10.3.7.4 South Korea Sepsis Diagnostics Market
10.3.7.4.1 South Korea Sepsis Diagnostics Market by Method
10.3.7.4.2 South Korea Sepsis Diagnostics Market by Test Type
10.3.7.4.3 South Korea Sepsis Diagnostics Market by Pathogen
10.3.7.4.4 South Korea Sepsis Diagnostics Market by Product
10.3.7.4.5 South Korea Sepsis Diagnostics Market by End-User
10.3.7.4.6 South Korea Sepsis Diagnostics Market by Technology
10.3.7.5 Singapore Sepsis Diagnostics Market
10.3.7.5.1 Singapore Sepsis Diagnostics Market by Method
10.3.7.5.2 Singapore Sepsis Diagnostics Market by Test Type
10.3.7.5.3 Singapore Sepsis Diagnostics Market by Pathogen
10.3.7.5.4 Singapore Sepsis Diagnostics Market by Product
10.3.7.5.5 Singapore Sepsis Diagnostics Market by End-User
10.3.7.5.6 Singapore Sepsis Diagnostics Market by Technology
10.3.7.6 Malaysia Sepsis Diagnostics Market
10.3.7.6.1 Malaysia Sepsis Diagnostics Market by Method
10.3.7.6.2 Malaysia Sepsis Diagnostics Market by Test Type
10.3.7.6.3 Malaysia Sepsis Diagnostics Market by Pathogen
10.3.7.6.4 Malaysia Sepsis Diagnostics Market by Product
10.3.7.6.5 Malaysia Sepsis Diagnostics Market by End-User
10.3.7.6.6 Malaysia Sepsis Diagnostics Market by Technology
10.3.7.7 Rest of Asia Pacific Sepsis Diagnostics Market
10.3.7.7.1 Rest of Asia Pacific Sepsis Diagnostics Market
10.3.7.7.2 Rest of Asia Pacific Sepsis Diagnostics Market by Method
10.3.7.7.3 Rest of Asia Pacific Sepsis Diagnostics Market by Test Type
10.3.7.7.4 Rest of Asia Pacific Sepsis Diagnostics Market by Pathogen
10.3.7.7.5 Rest of Asia Pacific Sepsis Diagnostics Market by Product
10.3.7.7.6 Rest of Asia Pacific Sepsis Diagnostics Market by End-User
10.3.7.7.7 Rest of Asia Pacific Sepsis Diagnostics Market by Technology
10.4 LAMEA Sepsis Diagnostics Market
10.4.1 LAMEA Sepsis Diagnostics Market by Method
10.4.1.1 LAMEA Conventional Market by Country
10.4.1.2 LAMEA Automated Market by Country
10.4.2 LAMEA Sepsis Diagnostics Market by Test Type
10.4.2.1 LAMEA Laboratory Tests Market by Country
10.4.2.2 LAMEA Point-of-Care Tests Market by Country
10.4.3 LAMEA Sepsis Diagnostics Market by Pathogen
10.4.3.1 LAMEA Bacterial Sepsis Market by Country
10.4.3.2 LAMEA Fungal Sepsis Market by Country
10.4.3.3 LAMEA Viral Sepsis Market by Country
10.4.3.4 LAMEA Others Market by Country
10.4.4 LAMEA Sepsis Diagnostics Market by Product
10.4.4.1 LAMEA Blood Culture Media Market by Country
10.4.4.2 LAMEA Assays & Reagents Market by Country
10.4.4.3 LAMEA Instruments Market by Country
10.4.4.4 LAMEA Software Market by Country
10.4.5 LAMEA Sepsis Diagnostics Market by End-User
10.4.5.1 LAMEA Hospitals & specialty clinics Market by Country
10.4.5.2 LAMEA Pathology & Reference Laboratories Market by Country
10.4.5.3 LAMEA Research Laboratories & Academic Institutes Market by Country
10.4.6 LAMEA Sepsis Diagnostics Market by Technology
10.4.6.1 LAMEA Blood Culture Market by Country
10.4.6.2 LAMEA Immunoassays Market by Country
10.4.6.3 LAMEA Molecular Diagnostics Market by Country
10.4.6.4 LAMEA Flow Cytometry Market by Country
10.4.6.5 LAMEA Microfluidics Market by Country
10.4.6.6 LAMEA Biomarkers Market by Country
10.4.7 LAMEA Sepsis Diagnostics Market by Country
10.4.7.1 Brazil Sepsis Diagnostics Market
10.4.7.1.1 Brazil Sepsis Diagnostics Market by Method
10.4.7.1.2 Brazil Sepsis Diagnostics Market by Test Type
10.4.7.1.3 Brazil Sepsis Diagnostics Market by Pathogen
10.4.7.1.4 Brazil Sepsis Diagnostics Market by Product
10.4.7.1.5 Brazil Sepsis Diagnostics Market by End-User
10.4.7.1.6 Brazil Sepsis Diagnostics Market by Technology
10.4.7.2 Argentina Sepsis Diagnostics Market
10.4.7.2.1 Argentina Sepsis Diagnostics Market by Method
10.4.7.2.2 Argentina Sepsis Diagnostics Market by Test Type
10.4.7.2.3 Argentina Sepsis Diagnostics Market by Pathogen
10.4.7.2.4 Argentina Sepsis Diagnostics Market by Product
10.4.7.2.5 Argentina Sepsis Diagnostics Market by End-User
10.4.7.2.6 Argentina Sepsis Diagnostics Market by Technology
10.4.7.3 UAE Sepsis Diagnostics Market
10.4.7.3.1 UAE Sepsis Diagnostics Market by Method
10.4.7.3.2 UAE Sepsis Diagnostics Market by Test Type
10.4.7.3.3 UAE Sepsis Diagnostics Market by Pathogen
10.4.7.3.4 UAE Sepsis Diagnostics Market by Product
10.4.7.3.5 UAE Sepsis Diagnostics Market by End-User
10.4.7.3.6 UAE Sepsis Diagnostics Market by Technology
10.4.7.4 Saudi Arabia Sepsis Diagnostics Market
10.4.7.4.1 Saudi Arabia Sepsis Diagnostics Market by Method
10.4.7.4.2 Saudi Arabia Sepsis Diagnostics Market by Test Type
10.4.7.4.3 Saudi Arabia Sepsis Diagnostics Market by Pathogen
10.4.7.4.4 Saudi Arabia Sepsis Diagnostics Market by Product
10.4.7.4.5 Saudi Arabia Sepsis Diagnostics Market by End-User
10.4.7.4.6 Saudi Arabia Sepsis Diagnostics Market by Technology
10.4.7.5 South Africa Sepsis Diagnostics Market
10.4.7.5.1 South Africa Sepsis Diagnostics Market by Method
10.4.7.5.2 South Africa Sepsis Diagnostics Market by Test Type
10.4.7.5.3 South Africa Sepsis Diagnostics Market by Pathogen
10.4.7.5.4 South Africa Sepsis Diagnostics Market by Product
10.4.7.5.5 South Africa Sepsis Diagnostics Market by End-User
10.4.7.5.6 South Africa Sepsis Diagnostics Market by Technology
10.4.7.6 Nigeria Sepsis Diagnostics Market
10.4.7.6.1 Nigeria Sepsis Diagnostics Market by Method
10.4.7.6.2 Nigeria Sepsis Diagnostics Market by Test Type
10.4.7.6.3 Nigeria Sepsis Diagnostics Market by Pathogen
10.4.7.6.4 Nigeria Sepsis Diagnostics Market by Product
10.4.7.6.5 Nigeria Sepsis Diagnostics Market by End-User
10.4.7.6.6 Nigeria Sepsis Diagnostics Market by Technology
10.4.7.7 Rest of LAMEA Sepsis Diagnostics Market
10.4.7.7.1 Rest of LAMEA Sepsis Diagnostics Market by Method
10.4.7.7.2 Rest of LAMEA Sepsis Diagnostics Market by Test Type
10.4.7.7.3 Rest of LAMEA Sepsis Diagnostics Market by Pathogen
10.4.7.7.4 Rest of LAMEA Sepsis Diagnostics Market by Product
10.4.7.7.5 Rest of LAMEA Sepsis Diagnostics Market by End-User
10.4.7.7.6 Rest of LAMEA Sepsis Diagnostics Market by Technology


Chapter 11. Company Profiles
11.1 BioMérieux S.A.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Acquisition and Mergers:
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Approvals and Trials:
11.3 Becton, Dickinson and Company
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Product Launches and Product Expansions:
11.4 Abbott Laboratories
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Thermo Fisher Scientific, Inc.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Approvals and Trials:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 DiaSorin S.p.A. (Luminex Corporation)
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Acquisitions and Mergers:
11.7 Bruker Corporation
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Product Launches and Product Expansions:
11.7.5.2 Acquisition and Mergers:
11.8 Siemens Healthineers AG (Siemens AG)
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental and Regional Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Partnerships, Collaborations, and Agreements:
11.8.5.2 Acquisition and Mergers:
11.9 Danaher Corporation
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.10. Quidel Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 Recent strategies and developments:
11.10.5.1 Acquisition and Mergers:
TABLE 1 Global Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 Global Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Sepsis Diagnostics Market
TABLE 4 Product Launches And Product Expansions – Sepsis Diagnostics Market
TABLE 5 Acquisition and Mergers – Sepsis Diagnostics Market
TABLE 6 Approvals and Trials – Sepsis Diagnostics Market
TABLE 7 Global Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 8 Global Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 9 Global Conventional Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Conventional Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Automated Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Automated Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 14 Global Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 15 Global Laboratory Tests Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Laboratory Tests Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Point-of-Care Tests Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Point-of-Care Tests Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 20 Global Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 21 Global Bacterial Sepsis Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Bacterial Sepsis Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Fungal Sepsis Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Fungal Sepsis Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Viral Sepsis Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Viral Sepsis Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 30 Global Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 31 Global Blood Culture Media Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Blood Culture Media Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Assays & Reagents Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Assays & Reagents Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Instruments Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Instruments Market by Region, 2022 - 2028, USD Million
TABLE 37 Global Software Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Software Market by Region, 2022 - 2028, USD Million
TABLE 39 Global Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 40 Global Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 41 Global Hospitals & specialty clinics Market by Region, 2018 - 2021, USD Million
TABLE 42 Global Hospitals & specialty clinics Market by Region, 2022 - 2028, USD Million
TABLE 43 Global Pathology & Reference Laboratories Market by Region, 2018 - 2021, USD Million
TABLE 44 Global Pathology & Reference Laboratories Market by Region, 2022 - 2028, USD Million
TABLE 45 Global Research Laboratories & Academic Institutes Market by Region, 2018 - 2021, USD Million
TABLE 46 Global Research Laboratories & Academic Institutes Market by Region, 2022 - 2028, USD Million
TABLE 47 Global Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 48 Global Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 49 Global Blood Culture Market by Region, 2018 - 2021, USD Million
TABLE 50 Global Blood Culture Market by Region, 2022 - 2028, USD Million
TABLE 51 Global Immunoassays Market by Region, 2018 - 2021, USD Million
TABLE 52 Global Immunoassays Market by Region, 2022 - 2028, USD Million
TABLE 53 Global Molecular Diagnostics Market by Region, 2018 - 2021, USD Million
TABLE 54 Global Molecular Diagnostics Market by Region, 2022 - 2028, USD Million
TABLE 55 Global Flow Cytometry Market by Region, 2018 - 2021, USD Million
TABLE 56 Global Flow Cytometry Market by Region, 2022 - 2028, USD Million
TABLE 57 Global Microfluidics Market by Region, 2018 - 2021, USD Million
TABLE 58 Global Microfluidics Market by Region, 2022 - 2028, USD Million
TABLE 59 Global Biomarkers Market by Region, 2018 - 2021, USD Million
TABLE 60 Global Biomarkers Market by Region, 2022 - 2028, USD Million
TABLE 61 Global Sepsis Diagnostics Market by Region, 2018 - 2021, USD Million
TABLE 62 Global Sepsis Diagnostics Market by Region, 2022 - 2028, USD Million
TABLE 63 North America Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 64 North America Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 65 North America Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 66 North America Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 67 North America Conventional Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Conventional Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Automated Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Automated Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 72 North America Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 73 North America Laboratory Tests Market by Country, 2018 - 2021, USD Million
TABLE 74 North America Laboratory Tests Market by Country, 2022 - 2028, USD Million
TABLE 75 North America Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
TABLE 76 North America Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
TABLE 77 North America Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 78 North America Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 79 North America Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 80 North America Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 81 North America Fungal Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 82 North America Fungal Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 83 North America Viral Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 84 North America Viral Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 85 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 86 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 87 North America Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 88 North America Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 89 North America Blood Culture Media Market by Country, 2018 - 2021, USD Million
TABLE 90 North America Blood Culture Media Market by Country, 2022 - 2028, USD Million
TABLE 91 North America Assays & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 92 North America Assays & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 93 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 94 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 95 North America Software Market by Country, 2018 - 2021, USD Million
TABLE 96 North America Software Market by Country, 2022 - 2028, USD Million
TABLE 97 North America Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 98 North America Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 99 North America Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
TABLE 100 North America Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
TABLE 101 North America Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 102 North America Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 103 North America Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 104 North America Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 105 North America Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 106 North America Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 107 North America Blood Culture Market by Country, 2018 - 2021, USD Million
TABLE 108 North America Blood Culture Market by Country, 2022 - 2028, USD Million
TABLE 109 North America Immunoassays Market by Country, 2018 - 2021, USD Million
TABLE 110 North America Immunoassays Market by Country, 2022 - 2028, USD Million
TABLE 111 North America Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 112 North America Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 113 North America Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 114 North America Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 115 North America Microfluidics Market by Country, 2018 - 2021, USD Million
TABLE 116 North America Microfluidics Market by Country, 2022 - 2028, USD Million
TABLE 117 North America Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 118 North America Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 119 North America Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 120 North America Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 121 US Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 122 US Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 123 US Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 124 US Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 125 US Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 126 US Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 127 US Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 128 US Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 129 US Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 130 US Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 131 US Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 132 US Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 133 US Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 134 US Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 135 Canada Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 136 Canada Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 137 Canada Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 138 Canada Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 139 Canada Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 140 Canada Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 141 Canada Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 142 Canada Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 143 Canada Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 144 Canada Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 145 Canada Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 146 Canada Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 147 Canada Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 148 Canada Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 149 Mexico Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 150 Mexico Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 151 Mexico Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 152 Mexico Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 153 Mexico Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 154 Mexico Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 155 Mexico Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 156 Mexico Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 157 Mexico Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 158 Mexico Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 159 Mexico Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 160 Mexico Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 161 Mexico Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 162 Mexico Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 163 Rest of North America Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 164 Rest of North America Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 165 Rest of North America Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 166 Rest of North America Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 167 Rest of North America Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 168 Rest of North America Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 169 Rest of North America Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 170 Rest of North America Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 171 Rest of North America Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 172 Rest of North America Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 173 Rest of North America Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 174 Rest of North America Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 175 Rest of North America Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 176 Rest of North America Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 177 Europe Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 178 Europe Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 179 Europe Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 180 Europe Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 181 Europe Conventional Market by Country, 2018 - 2021, USD Million
TABLE 182 Europe Conventional Market by Country, 2022 - 2028, USD Million
TABLE 183 Europe Automated Market by Country, 2018 - 2021, USD Million
TABLE 184 Europe Automated Market by Country, 2022 - 2028, USD Million
TABLE 185 Europe Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 186 Europe Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 187 Europe Laboratory Tests Market by Country, 2018 - 2021, USD Million
TABLE 188 Europe Laboratory Tests Market by Country, 2022 - 2028, USD Million
TABLE 189 Europe Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
TABLE 190 Europe Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
TABLE 191 Europe Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 192 Europe Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 193 Europe Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 194 Europe Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 195 Europe Fungal Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 196 Europe Fungal Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 197 Europe Viral Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 198 Europe Viral Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 199 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 200 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 201 Europe Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 202 Europe Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 203 Europe Blood Culture Media Market by Country, 2018 - 2021, USD Million
TABLE 204 Europe Blood Culture Media Market by Country, 2022 - 2028, USD Million
TABLE 205 Europe Assays & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 206 Europe Assays & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 207 Europe Instruments Market by Country, 2018 - 2021, USD Million
TABLE 208 Europe Instruments Market by Country, 2022 - 2028, USD Million
TABLE 209 Europe Software Market by Country, 2018 - 2021, USD Million
TABLE 210 Europe Software Market by Country, 2022 - 2028, USD Million
TABLE 211 Europe Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 212 Europe Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 213 Europe Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
TABLE 214 Europe Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
TABLE 215 Europe Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 216 Europe Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 217 Europe Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 218 Europe Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 219 Europe Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 220 Europe Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 221 Europe Blood Culture Market by Country, 2018 - 2021, USD Million
TABLE 222 Europe Blood Culture Market by Country, 2022 - 2028, USD Million
TABLE 223 Europe Immunoassays Market by Country, 2018 - 2021, USD Million
TABLE 224 Europe Immunoassays Market by Country, 2022 - 2028, USD Million
TABLE 225 Europe Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 226 Europe Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 227 Europe Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 228 Europe Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 229 Europe Microfluidics Market by Country, 2018 - 2021, USD Million
TABLE 230 Europe Microfluidics Market by Country, 2022 - 2028, USD Million
TABLE 231 Europe Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 232 Europe Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 233 Europe Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 234 Europe Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 235 Germany Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 236 Germany Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 237 Germany Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 238 Germany Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 239 Germany Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 240 Germany Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 241 Germany Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 242 Germany Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 243 Germany Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 244 Germany Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 245 Germany Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 246 Germany Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 247 Germany Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 248 Germany Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 249 UK Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 250 UK Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 251 UK Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 252 UK Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 253 UK Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 254 UK Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 255 UK Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 256 UK Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 257 UK Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 258 UK Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 259 UK Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 260 UK Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 261 UK Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 262 UK Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 263 France Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 264 France Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 265 France Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 266 France Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 267 France Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 268 France Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 269 France Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 270 France Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 271 France Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 272 France Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 273 France Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 274 France Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 275 France Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 276 France Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 277 Russia Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 278 Russia Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 279 Russia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 280 Russia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 281 Russia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 282 Russia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 283 Russia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 284 Russia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 285 Russia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 286 Russia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 287 Russia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 288 Russia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 289 Russia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 290 Russia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 291 Spain Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 292 Spain Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 293 Spain Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 294 Spain Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 295 Spain Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 296 Spain Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 297 Spain Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 298 Spain Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 299 Spain Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 300 Spain Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 301 Spain Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 302 Spain Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 303 Spain Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 304 Spain Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 305 Italy Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 306 Italy Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 307 Italy Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 308 Italy Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 309 Italy Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 310 Italy Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 311 Italy Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 312 Italy Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 313 Italy Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 314 Italy Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 315 Italy Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 316 Italy Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 317 Italy Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 318 Italy Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 319 Rest of Europe Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 320 Rest of Europe Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 321 Rest of Europe Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 322 Rest of Europe Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 323 Rest of Europe Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 324 Rest of Europe Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 325 Rest of Europe Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 326 Rest of Europe Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 327 Rest of Europe Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 328 Rest of Europe Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 329 Rest of Europe Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 330 Rest of Europe Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 331 Rest of Europe Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 332 Rest of Europe Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 333 Asia Pacific Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 334 Asia Pacific Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 335 Asia Pacific Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 336 Asia Pacific Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 337 Asia Pacific Conventional Market by Country, 2018 - 2021, USD Million
TABLE 338 Asia Pacific Conventional Market by Country, 2022 - 2028, USD Million
TABLE 339 Asia Pacific Automated Market by Country, 2018 - 2021, USD Million
TABLE 340 Asia Pacific Automated Market by Country, 2022 - 2028, USD Million
TABLE 341 Asia Pacific Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 342 Asia Pacific Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 343 Asia Pacific Laboratory Tests Market by Country, 2018 - 2021, USD Million
TABLE 344 Asia Pacific Laboratory Tests Market by Country, 2022 - 2028, USD Million
TABLE 345 Asia Pacific Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
TABLE 346 Asia Pacific Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
TABLE 347 Asia Pacific Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 348 Asia Pacific Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 349 Asia Pacific Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 350 Asia Pacific Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 351 Asia Pacific Fungal Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 352 Asia Pacific Fungal Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 353 Asia Pacific Viral Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 354 Asia Pacific Viral Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 355 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 356 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 357 Asia Pacific Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 358 Asia Pacific Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 359 Asia Pacific Blood Culture Media Market by Country, 2018 - 2021, USD Million
TABLE 360 Asia Pacific Blood Culture Media Market by Country, 2022 - 2028, USD Million
TABLE 361 Asia Pacific Assays & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 362 Asia Pacific Assays & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 363 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
TABLE 364 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
TABLE 365 Asia Pacific Software Market by Country, 2018 - 2021, USD Million
TABLE 366 Asia Pacific Software Market by Country, 2022 - 2028, USD Million
TABLE 367 Asia Pacific Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 368 Asia Pacific Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 369 Asia Pacific Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
TABLE 370 Asia Pacific Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
TABLE 371 Asia Pacific Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 372 Asia Pacific Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 373 Asia Pacific Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 374 Asia Pacific Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 375 Asia Pacific Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 376 Asia Pacific Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 377 Asia Pacific Blood Culture Market by Country, 2018 - 2021, USD Million
TABLE 378 Asia Pacific Blood Culture Market by Country, 2022 - 2028, USD Million
TABLE 379 Asia Pacific Immunoassays Market by Country, 2018 - 2021, USD Million
TABLE 380 Asia Pacific Immunoassays Market by Country, 2022 - 2028, USD Million
TABLE 381 Asia Pacific Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 382 Asia Pacific Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 383 Asia Pacific Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 384 Asia Pacific Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 385 Asia Pacific Microfluidics Market by Country, 2018 - 2021, USD Million
TABLE 386 Asia Pacific Microfluidics Market by Country, 2022 - 2028, USD Million
TABLE 387 Asia Pacific Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 388 Asia Pacific Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 389 Asia Pacific Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 390 Asia Pacific Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 391 China Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 392 China Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 393 China Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 394 China Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 395 China Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 396 China Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 397 China Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 398 China Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 399 China Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 400 China Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 401 China Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 402 China Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 403 China Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 404 China Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 405 Japan Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 406 Japan Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 407 Japan Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 408 Japan Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 409 Japan Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 410 Japan Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 411 Japan Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 412 Japan Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 413 Japan Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 414 Japan Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 415 Japan Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 416 Japan Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 417 Japan Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 418 Japan Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 419 India Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 420 India Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 421 India Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 422 India Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 423 India Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 424 India Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 425 India Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 426 India Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 427 India Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 428 India Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 429 India Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 430 India Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 431 India Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 432 India Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 433 South Korea Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 434 South Korea Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 435 South Korea Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 436 South Korea Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 437 South Korea Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 438 South Korea Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 439 South Korea Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 440 South Korea Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 441 South Korea Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 442 South Korea Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 443 South Korea Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 444 South Korea Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 445 South Korea Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 446 South Korea Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 447 Singapore Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 448 Singapore Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 449 Singapore Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 450 Singapore Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 451 Singapore Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 452 Singapore Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 453 Singapore Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 454 Singapore Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 455 Singapore Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 456 Singapore Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 457 Singapore Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 458 Singapore Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 459 Singapore Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 460 Singapore Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 461 Malaysia Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 462 Malaysia Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 463 Malaysia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 464 Malaysia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 465 Malaysia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 466 Malaysia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 467 Malaysia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 468 Malaysia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 469 Malaysia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 470 Malaysia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 471 Malaysia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 472 Malaysia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 473 Malaysia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 474 Malaysia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 475 Rest of Asia Pacific Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 476 Rest of Asia Pacific Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 477 Rest of Asia Pacific Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 478 Rest of Asia Pacific Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 479 Rest of Asia Pacific Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 480 Rest of Asia Pacific Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 481 Rest of Asia Pacific Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 482 Rest of Asia Pacific Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 483 Rest of Asia Pacific Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 484 Rest of Asia Pacific Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 485 Rest of Asia Pacific Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 486 Rest of Asia Pacific Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 487 Rest of Asia Pacific Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 488 Rest of Asia Pacific Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 489 Rest of Asia Pacific Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 490 LAMEA Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 491 LAMEA Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 492 LAMEA Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 493 LAMEA Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 494 LAMEA Conventional Market by Country, 2018 - 2021, USD Million
TABLE 495 LAMEA Conventional Market by Country, 2022 - 2028, USD Million
TABLE 496 LAMEA Automated Market by Country, 2018 - 2021, USD Million
TABLE 497 LAMEA Automated Market by Country, 2022 - 2028, USD Million
TABLE 498 LAMEA Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 499 LAMEA Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 500 LAMEA Laboratory Tests Market by Country, 2018 - 2021, USD Million
TABLE 501 LAMEA Laboratory Tests Market by Country, 2022 - 2028, USD Million
TABLE 502 LAMEA Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
TABLE 503 LAMEA Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
TABLE 504 LAMEA Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 505 LAMEA Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 506 LAMEA Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 507 LAMEA Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 508 LAMEA Fungal Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 509 LAMEA Fungal Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 510 LAMEA Viral Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 511 LAMEA Viral Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 512 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 513 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 514 LAMEA Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 515 LAMEA Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 516 LAMEA Blood Culture Media Market by Country, 2018 - 2021, USD Million
TABLE 517 LAMEA Blood Culture Media Market by Country, 2022 - 2028, USD Million
TABLE 518 LAMEA Assays & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 519 LAMEA Assays & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 520 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
TABLE 521 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
TABLE 522 LAMEA Software Market by Country, 2018 - 2021, USD Million
TABLE 523 LAMEA Software Market by Country, 2022 - 2028, USD Million
TABLE 524 LAMEA Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 525 LAMEA Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 526 LAMEA Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
TABLE 527 LAMEA Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
TABLE 528 LAMEA Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 529 LAMEA Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 530 LAMEA Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 531 LAMEA Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 532 LAMEA Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 533 LAMEA Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 534 LAMEA Blood Culture Market by Country, 2018 - 2021, USD Million
TABLE 535 LAMEA Blood Culture Market by Country, 2022 - 2028, USD Million
TABLE 536 LAMEA Immunoassays Market by Country, 2018 - 2021, USD Million
TABLE 537 LAMEA Immunoassays Market by Country, 2022 - 2028, USD Million
TABLE 538 LAMEA Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 539 LAMEA Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 540 LAMEA Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 541 LAMEA Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 542 LAMEA Microfluidics Market by Country, 2018 - 2021, USD Million
TABLE 543 LAMEA Microfluidics Market by Country, 2022 - 2028, USD Million
TABLE 544 LAMEA Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 545 LAMEA Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 546 LAMEA Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 547 LAMEA Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 548 Brazil Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 549 Brazil Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 550 Brazil Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 551 Brazil Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 552 Brazil Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 553 Brazil Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 554 Brazil Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 555 Brazil Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 556 Brazil Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 557 Brazil Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 558 Brazil Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 559 Brazil Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 560 Brazil Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 561 Brazil Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 562 Argentina Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 563 Argentina Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 564 Argentina Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 565 Argentina Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 566 Argentina Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 567 Argentina Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 568 Argentina Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 569 Argentina Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 570 Argentina Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 571 Argentina Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 572 Argentina Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 573 Argentina Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 574 Argentina Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 575 Argentina Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 576 UAE Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 577 UAE Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 578 UAE Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 579 UAE Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 580 UAE Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 581 UAE Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 582 UAE Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 583 UAE Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 584 UAE Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 585 UAE Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 586 UAE Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 587 UAE Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 588 UAE Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 589 UAE Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 590 Saudi Arabia Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 591 Saudi Arabia Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 592 Saudi Arabia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 593 Saudi Arabia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 594 Saudi Arabia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 595 Saudi Arabia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 596 Saudi Arabia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 597 Saudi Arabia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 598 Saudi Arabia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 599 Saudi Arabia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 600 Saudi Arabia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 601 Saudi Arabia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 602 Saudi Arabia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 603 Saudi Arabia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 604 South Africa Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 605 South Africa Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 606 South Africa Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 607 South Africa Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 608 South Africa Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 609 South Africa Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 610 South Africa Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 611 South Africa Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 612 South Africa Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 613 South Africa Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 614 South Africa Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 615 South Africa Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 616 South Africa Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 617 South Africa Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 618 Nigeria Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 619 Nigeria Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 620 Nigeria Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 621 Nigeria Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 622 Nigeria Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 623 Nigeria Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 624 Nigeria Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 625 Nigeria Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 626 Nigeria Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 627 Nigeria Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 628 Nigeria Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 629 Nigeria Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 630 Nigeria Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 631 Nigeria Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 632 Rest of LAMEA Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 633 Rest of LAMEA Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 634 Rest of LAMEA Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 635 Rest of LAMEA Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 636 Rest of LAMEA Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 637 Rest of LAMEA Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 638 Rest of LAMEA Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 639 Rest of LAMEA Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 640 Rest of LAMEA Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 641 Rest of LAMEA Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 642 Rest of LAMEA Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 643 Rest of LAMEA Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 644 Rest of LAMEA Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 645 Rest of LAMEA Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 646 Key information – BioMérieux S.A.
TABLE 647 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 648 Key information – Becton, Dickinson and Company
TABLE 649 Key Information – Abbott Laboratories
TABLE 650 Key Information – Thermo Fisher Scientific, Inc.
TABLE 651 Key Information – DiaSorin S.p.A.
TABLE 652 Key Information – Bruker Corporation
TABLE 653 Key Information – Siemens Healthineers AG
TABLE 654 Key Information – Danaher Corporation
TABLE 655 key information – Quidel Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2021, Dec) Leading Players
FIG 5 Global Sepsis Diagnostics Market Share by Method, 2021
FIG 6 Global Sepsis Diagnostics Market Share by Method, 2028
FIG 7 Global Sepsis Diagnostics Market by Method, 2018 - 2028, USD Million
FIG 8 Global Sepsis Diagnostics Market Share by Test Type, 2021
FIG 9 Global Sepsis Diagnostics Market Share by Test Type, 2028
FIG 10 Global Sepsis Diagnostics Market by Test Type, 2018 - 2028, USD Million
FIG 11 Global Sepsis Diagnostics Market Share by Pathogen, 2021
FIG 12 Global Sepsis Diagnostics Market Share by Pathogen, 2028
FIG 13 Global Sepsis Diagnostics Market by Pathogen, 2018 - 2028, USD Million
FIG 14 Global Sepsis Diagnostics Market Share by Product, 2021
FIG 15 Global Sepsis Diagnostics Market Share by Product, 2028
FIG 16 Global Sepsis Diagnostics Market by Product, 2018 - 2028, USD Million
FIG 17 Global Sepsis Diagnostics Market Share by End-User, 2021
FIG 18 Global Sepsis Diagnostics Market Share by End-User, 2028
FIG 19 Global Sepsis Diagnostics Market by End-User, 2018 - 2028, USD Million
FIG 20 Global Sepsis Diagnostics Market Share by Technology, 2021
FIG 21 Global Sepsis Diagnostics Market Share by Technology, 2028
FIG 22 Global Sepsis Diagnostics Market by Technology, 2018 - 2028, USD Million
FIG 23 Global Sepsis Diagnostics Market Share by Region, 2021
FIG 24 Global Sepsis Diagnostics Market Share by Region, 2028
FIG 25 Global Sepsis Diagnostics Market by Region, 2018 - 2028, USD Million
FIG 26 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 27 Swot analysis: thermo fisher scientific, inc.
FIG 28 Recent strategies and developments: Bruker Corporation

Purchase Full Report of
Sepsis Diagnostics Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL

© 2024 KBV Research. All Rights Reserved